柠檬酸杆菌属对多种抗菌剂的体外敏感性
In vitro susceptibility of Citrobacter species to various antimicrobial agents.
作者信息
Samonis G, Ho D H, Gooch G F, Rolston K V, Bodey G P
出版信息
Antimicrob Agents Chemother. 1987 May;31(5):829-30. doi: 10.1128/AAC.31.5.829.
Abstract
The in vitro activities of 16 antimicrobial agents against 14 clinical isolates of Citrobacter diversus and 27 isolates of Citrobacter freundii were studied. C. freundii isolates were more resistant, being susceptible only to amikacin, netilmicin, gentamicin, imipenem, ciprofloxacin, and enoxacin. C. diversus isolates were susceptible to many more of the agents tested.
摘要
研究了16种抗菌药物对14株不同种柠檬酸杆菌临床分离株和27株弗氏柠檬酸杆菌分离株的体外活性。弗氏柠檬酸杆菌分离株耐药性更强，仅对阿米卡星、奈替米星、庆大霉素、亚胺培南、环丙沙星和依诺沙星敏感。不同种柠檬酸杆菌分离株对更多所测试的药物敏感。
相似文献
1
In vitro susceptibility of Citrobacter species to various antimicrobial agents.柠檬酸杆菌属对多种抗菌剂的体外敏感性
Antimicrob Agents Chemother. 1987 May;31(5):829-30. doi: 10.1128/AAC.31.5.829.
2
Citrobacter bacteremia in a tertiary care hospital.三级护理医院中的柠檬酸杆菌菌血症
Scand J Infect Dis. 2003;35(10):765-8. doi: 10.1080/00365540310016376.
3
Antimicrobial susceptibility patterns (antibiograms) as an aid in differentiating Citrobacter species.
Am J Clin Pathol. 1977 Feb;67(2):187-9. doi: 10.1093/ajcp/67.2.187.
4
Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.两个不同时间段弗氏柠檬酸杆菌分离株的抗菌药敏性比较。
J Microbiol Immunol Infect. 2000 Dec;33(4):258-62.
5
Antimicrobial activity of imipenem against 1386 clinical isolates.亚胺培南对1386株临床分离菌的抗菌活性。
Methods Find Exp Clin Pharmacol. 1986 Nov;8(11):675-8.
6
Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).血流感染中产诱导型AmpCβ-内酰胺酶的革兰氏阴性杆菌：一项全国性监测项目（SCOPE）中的发生率、抗菌药物敏感性及分子流行病学
Diagn Microbiol Infect Dis. 1997 Aug;28(4):211-9. doi: 10.1016/s0732-8893(97)00064-3.
7
Epidemic infection caused by Citrobacter rodentium in a gerbil colony.沙鼠群体中由啮齿柠檬酸杆菌引起的流行性感染。
Vet Rec. 1999 Oct 2;145(14):400-3. doi: 10.1136/vr.145.14.400.
8
Antibiotic sensitivity pattern of Citrobacter isolated from various clinical specimens in a tertiary care hospital.从一家三级护理医院的各种临床标本中分离出的柠檬酸杆菌的抗生素敏感性模式。
Indian J Pathol Microbiol. 2007 Jul;50(3):666-8.
9
In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
J Chemother. 1992 Oct;4(5):263-7. doi: 10.1080/1120009x.1992.11739174.
10
Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.中国某教学医院耐碳青霉烯阴沟肠杆菌的检测与传播。
Am J Infect Control. 2011 Nov;39(9):e55-60. doi: 10.1016/j.ajic.2011.02.009. Epub 2011 Jun 25.
引用本文的文献
1
Comparative Genomic Analysis of and Key Genes Essential for the Pathogenicity of .[病原体名称]的比较基因组分析及[病原体名称]致病性关键基因分析
Front Microbiol. 2019 Dec 6;10:2774. doi: 10.3389/fmicb.2019.02774. eCollection 2019.
2
Community-Acquired Pneumonia and Empyema Caused by Citrobacter koseri in an Immunocompetent Patient.免疫功能正常患者由科氏柠檬酸杆菌引起的社区获得性肺炎和脓胸
Case Rep Pulmonol. 2015;2015:670373. doi: 10.1155/2015/670373. Epub 2015 Nov 8.
3
Complete Genome Sequence of Citrobacter freundii Myophage Moon.弗氏柠檬酸杆菌噬菌体Moon的全基因组序列
Genome Announc. 2015 Jan 29;3(1):e01427-14. doi: 10.1128/genomeA.01427-14.
4
Multidrug resistant citrobacter: an unusual cause of liver abscess.多重耐药柠檬酸杆菌：肝脓肿的罕见病因。
BMJ Case Rep. 2013 Apr 22;2013:bcr2013008714. doi: 10.1136/bcr-2013-008714.
5
Citrobacter brain abscesses in neonates: early surgical intervention and review of the literature.新生儿柠檬酸杆菌脑脓肿：早期手术干预及文献综述
Childs Nerv Syst. 2012 Oct;28(10):1715-22. doi: 10.1007/s00381-012-1746-4. Epub 2012 Apr 15.
6
Citrobacter infections in a general hospital: characteristics and outcomes.综合医院中的柠檬酸杆菌感染：特征与转归
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):61-8. doi: 10.1007/s10096-008-0598-z. Epub 2008 Aug 6.
7
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
8
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
9
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
10
Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.16年期间癌症患者柠檬酸杆菌血症的回顾。
Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):479-85. doi: 10.1007/BF01963933.
本文引用的文献
1
Comparative in vitro study of SQ26,776.SQ26,776的体外对比研究。
Antimicrob Agents Chemother. 1982 Feb;21(2):294-8. doi: 10.1128/AAC.21.2.294.
2
Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature.人类柠檬酸杆菌感染：西雅图退伍军人管理局医疗中心的经验及文献综述。
Rev Infect Dis. 1980 Sep-Oct;2(5):746-60. doi: 10.1093/clinids/2.5.746.
3
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.与其他抗生素相比，WIN 49375对癌症患者分离菌株的体外活性。
Antimicrob Agents Chemother. 1984 Sep;26(3):421-3. doi: 10.1128/AAC.26.3.421.
4
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.急性白血病患者循环白细胞与感染之间的定量关系。
Ann Intern Med. 1966 Feb;64(2):328-40. doi: 10.7326/0003-4819-64-2-328.
5
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.喹诺酮抗菌剂A - 56619和A - 56620的体外活性
Antimicrob Agents Chemother. 1985 Oct;28(4):514-20. doi: 10.1128/AAC.28.4.514.
6
Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.奇异柠檬酸杆菌和弗氏柠檬酸杆菌引起的菌血症。发病率、危险因素及临床转归。
Arch Intern Med. 1985 Oct;145(10):1808-10.
7
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.新型广谱头孢菌素BMY-28142的体外活性评估
Antimicrob Agents Chemother. 1985 May;27(5):679-82. doi: 10.1128/AAC.27.5.679.
8
In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.新型广谱头孢菌素YM-13115抗菌活性的体外研究
Antimicrob Agents Chemother. 1985 Apr;27(4):565-9. doi: 10.1128/AAC.27.4.565.
9
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.依诺沙星、替卡西林加克拉维酸、氨曲南、哌拉西林和亚胺培南的体外活性及其与常用抗菌药物的比较。
Antimicrob Agents Chemother. 1985 Aug;28(2):259-64. doi: 10.1128/AAC.28.2.259.
10
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.新型广谱头孢菌素BMY-28142的体外抗菌活性
Antimicrob Agents Chemother. 1985 Apr;27(4):574-7. doi: 10.1128/AAC.27.4.574.
Zotero 插件